Member Info for ademcg

but hopefully it won't reach that, 2 big ish buys came through late in the session, over 1 Mill each....Digital look states regular trades, but as yet not sure true status yet. GL ALL

only 2 buys today, the rest sells...perhaps time to take profit, wait for retrace and buy back in.

not thinking of selling although keeping an eye on my charts....great run up from 5p for me :) Long may it continue.

but I would rather they kept the Divi and invested it. Great set of numbers...good fundamentals, whats not to like ? GL ALL

:) http://www.investegate.co.uk/Article.aspx?id=200903180700090221P

Financial performance Throughout the year the Group achieved strong sales growth with steady margins, well controlled costs and solid cash generation. Turnover was up 20% on the previous year to £21.8m. Sales benefited from the continuing success of the Hydromol® range, the build up of Deltacortril® to higher production levels, the benefits of both volume growth and a favourable euro exchange rate on our sales of Nu-Seals® in Ireland, and the growth of Forceval® in China. Gross margins benefited from product mix effects together with foreign exchange gains and were 51.2%, up from 49.0% the previous year. We expect underlying margins to remain broadly steady at around 50%. We are experiencing some modest cost pressure from suppliers, but have a programme of efficiency improvements to help offset it. Operating costs remain well controlled, and the restructuring in mid-2007 has successfully delivered more than £1m per annum of cost savings. The outcome of the strong sales growth and the containment in operating costs is that operating profit grew to £6.4m, an increase of 76% over the previous year's pre-exceptional figure of £3.6m. Pre-tax trading profit was ahead of expectations at £2.4m - a major advance on the previous year's £0.4m pre-exceptional trading profit. We also benefited from £0.6m received from HM Revenue & Customs following our successful claim for tax credits relating to R&a

Commenting on the results, Michael Gatenby, Alliance's Chairman, said: "We have established a new level of profitability in the business, which has created an exciting platform for our future growth. The current year has started well and, earlier this month, we were particularly pleased to welcome MVM Life Science Partners to our Board and shareholder register. We look forward to the coming year with great confidence." Business Review The resilience of our portfolio produces another record year Overview Alliance Pharma has now delivered its third successive half-year of much improved profitability since the restructuring and strategic changes announced in 2007. Sales, profits and cash generation all reached record levels in 2008 in a very encouraging year for the Group. These results reflect the resilience of the Group's portfolio, which, by being predominately prescription driven, is highly resistant to recessionary pressures. It also benefits from the continuing success of our dermatology strategy - spearheaded by the promotion of the Hydromol® range of products for eczema and other dry skin conditions. As a result of this strengthening financial performance, we have decided that the business is now reaching the appropriate point in its development to commence paying a dividend.

ALLIANCE PHARMA PLC ("Alliance" or "Alliance Pharma" or "the Group") Preliminary results for the year ended 31 December 2008 Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, is pleased to announce its preliminary results for the year ended 31 December 2008. Financial Highlights * Sales up 20% to £21.8m (2007: £18.2m) * Operating profit up 76% to £6.4m (2007: £3.6m before exceptional items) * Pre-tax profit six-fold increase to £2.4m (2007: £0.4m before exceptional items) * Adjusted EPS five-fold increase to 1.17p (2007: 0.23p) * Cash generated from operations up 28% to £5.2m (2007: £4.1m) * Dividend expected to commence within the next year Operational Highlights * Hydromol® sales growth of 38% * Sales of Deltacortril® doubled on improved production volumes * Acquisition of Pavacol-D® in August 2008 * Successful first full year in China - underlying sales of Forceval® up 11% * Over £1m of annual cost savings successfully delivered Commenting on the results, Michael Gatenby, Alliance's Chairman, said: "We have established a new level of profitability in the business, which has created an exciting platform for our future growth. The current year has started well and, earlie

Buy on Rumour, Sell on News....caution is the key word GL All

I read with interest your post of the 19th, immediately after posting it. I also took profits around the 75p mark, I was in @ 49p What i am interested in, and I am only starting off the Fib retrace research, is the significance of the percentages. When you posted: The recent lows of 40p and the recent highs of 82p give a 42p difference which we will apply Fibonacci theory to, to see which stop off points KAH is likely to make, here are the 4 key percentages that this might retrace to. 23.2%= 72.6p 38.2%=66.3p 50%= 61.1p 61.8%=56.04p Do the percentages point to the probability ? I.e. there is a 61.8% probability it will retrace to 56.01p? Thanks for posting too...I am a novice charter and use MACD, RSI and Stochastic regularly for entry / exit, but starting to learn candlestick patterns and EW theory...the more tools and indicators the better in my book :) I will be looking to get back in to KAH around the 55p mark me thinks. GL ALL

SENIOR POISED FOR FURTHER JOB CUTS A further 500 jobs are to be axed at engineering group Senior in the first four months of 2009, chief executive Mark Rollins has said. The additional cuts, following 500 last year, are expected to reduce costs by 19 million pounds in 2009. The announcement came as the company unveiled strong results for 2008, with pre-tax profits jumping 50 percent to 51.3 million pounds on revenue up 19 percent to 564.2 million pounds. The job cuts are seen as a result of weak land vehicle markets and poor business jet and regional markets.

18th Feb: How far off the recovery will be is anyones guess, but if I had the spare cash I would buy at sub 50p :) GL All So what Do I know ? I know its sub 50p and IF I had spare cash I would be buying...... :-O

If I had spare cash I would buy sub 50p. Here we are and when a bottom or support is reached I will buy in for a long term play.

where did the remaining 15 million shares go ? Hmmmm

I don't get the fact that so many shares (almost 30 Mil in total, or am I missing something?) were sold or changed ownership and the SP didn't budge ? If Goldshield were the recipients of these shares then the sp would of shot up ? Confused :/

up 10% today and systematic and regular trades of the same size. Someone knows something....I will search tonight ! GL ALL

another RNS came out at 16:47 today....: Emerging Metals Increases Stake RNS Number : 7522N Kalahari Minerals PLC 23 February 2009 Kalahari Minerals plc / Ticker: KAH / Index: AIM / Sector: Mining & Exploration 23 February 2009 Kalahari Minerals plc ('Kalahari' or 'the Company') Emerging Metals Increases Stake Kalahari Minerals plc, the AIM listed mining exploration group with a portfolio of copper, base metal and uranium interests in Namibia, was notified on 23 February 2009 that Emerging Metals Limited has purchased 2,475,000 ordinary shares in the Company, representing approximately 1.38% of the Company's total voting rights, raising its total interest in Kalahari to 15,820,000 ordinary shares representing 8.84% of its total voting rights.

great company, fundamentals are rock solid as is the business plan...just got to be a little careful about entry. GL ALL

EML represents a more cost effective route to the Uranium exposure (in a good way) :P I had KAH but sold with a nice profit last week as it fel for the first time. I had planned to buy back in but will lurk with intent and have bought EML just for the link back in. GL ALL

Taken private by management means that the management would takeover the company by buying out the shareholders then delist from AIM. Perhaps we would have to be bought out at a premium ?